This article has been cited by
1From Molecules to the Clinic: Linking Schizophrenia and Metabolic Syndrome through Sphingolipids Metabolism
Rolando I. Castillo,Leonel E. Rojo,Marcela Henriquez-Henriquez,Hernán Silva,Alejandro Maturana,María J. Villar,Manuel Fuentes,Pablo A. Gaspar
Frontiers in Neuroscience.2016;10()
[DOI]
2High prevalence of metabolic alterations in Latin American patients at initial stages of psychosis
Barbara Iruretagoyena,Carmen P. Castañeda,Juan Undurraga,Rubén Nachar,Cristian Mena,Carlos Gallardo,Nicolas A. Crossley,Alfonso Gonzalez-Valderrama
Early Intervention in Psychiatry.2019;13(6)1382
[DOI]
3Measurement of Metabolic Monitoring in Youth and Adult Medicaid Recipients Prescribed Antipsychotics
Gail A. Edelsohn,Meghna Parthasarathy,Lauren Terhorst,Irina O. Karpov,James Schuster
Journal of Managed Care & Specialty Pharmacy.2015;21(9)769
[DOI]
4The relation of vitamin D, metabolic risk and negative symptom severity in people with psychotic disorders
J. Bruins,F. Jörg,E.R. van den Heuvel,A.A. Bartels-Velthuis,E. Corpeleijn,F.A.J. Muskiet,G.H.M. Pijnenborg,R. Bruggeman
Schizophrenia Research.2018;195(9)513
[DOI]
5Complex Polypharmacy in Patients With Schizophrenia-Spectrum Disorders Before a Psychiatric Hospitalization
Brandon A. Gaudiano,Carolina Guzman Holst,Alexandra Morena,Lauren E. Reeves,Valerie J. Sydnor,Gary Epstein-Lubow,Lauren M. Weinstock
Journal of Clinical Psychopharmacology.2018;38(3)180
[DOI]
6Metabolic syndrome among psychiatric outpatients with mood and anxiety disorders
Ching-I Hung,Chia-Yih Liu,Mei-Chun Hsiao,Nan-Wen Yu,Chun-Lin Chu
BMC Psychiatry.2014;14(1)180
[DOI]
7Comparison of metabolic syndrome prevalence in patients with schizophrenia and bipolar I disorder
Razieh Nayerifard,majid akbari bureng,Alireza Zahiroddin,Massood Namjoo,Sepideh Rajezi
Diabetes & Metabolic Syndrome: Clinical Research & Reviews.2017;11(1)S411
[DOI]
8Metabolic syndrome and atypical antipsychotics: Possibility of prediction and control
Clara M. Franch Pato,Vicente Molina Rodríguez,Juan I. Franch Valverde
Revista de Psiquiatría y Salud Mental (English Edition).2017;10(1)38
[DOI]
9Factores determinantes del riesgo metabólico en el tratamiento con antipsicóticos atípicos
Clara M. Franch Pato,Vicente Molina Rodríguez,Juan I. Franch Valverde
Psiquiatría Biológica.2016;23(3)128
[DOI]
10The Obesity–Impulsivity Axis: Potential Metabolic Interventions in Chronic Psychiatric Patients
Adonis Sfera,Carolina Osorio,Luzmin Acosta Inderias,Victoria Parker,Amy I. Price,Michael Cummings
Frontiers in Psychiatry.2017;8(3)128
[DOI]
11Metabolic syndrome among psychiatric inpatients with schizophrenia in Indonesia
Marthoenis Marthoenis,Marion C. Aichberger,Ibrahim Puteh,Syahrial Syahrial,Meryam Schouler-Ocak
Asian Journal of Psychiatry.2015;15(3)10
[DOI]
12Beyond the brain: disrupted in schizophrenia 1 regulates pancreatic ß-cell function via glycogen synthase kinase-3ß
Agata Jurczyk,Anetta Nowosielska,Natalia Przewozniak,Ken-Edwin Aryee,Philip Dilorio,David Blodgett,Chaoxing Yang,Martha Campbell-Thompson,Mark Atkinson,Leonard Shultz,Ann Rittenhouse,David Harlan,Dale Greiner,Rita Bortell
The FASEB Journal.2016;30(2)983
[DOI]
13Prevalence and risk factors of metabolic syndrome among drug-naive psychotic patients
Nagy Fawzy,AmanyEl Shabrawy,Amira Youssef
Egyptian Journal of Psychiatry.2015;36(2)101
[DOI]
14Síndrome metabólico y antipsicóticos atípicos. Posibilidad de predicción y control
Clara M. Franch Pato,Vicente Molina Rodríguez,Juan I. Franch Valverde
Revista de Psiquiatría y Salud Mental.2017;10(1)38
[DOI]
15Novel Adverse Events of Iloperidone: A Disproportionality Analysis in US Food and Drug Administration Adverse Event Reporting System (FAERS) Database
Viswam Subeesh,Eswaran Maheswari,Hemendra Singh,Thomas Elsa Beulah,Ann Mary Swaroop
Current Drug Safety.2019;14(1)21
[DOI]
16Novel Adverse Events of Iloperidone: A Disproportionality Analysis in US Food and Drug Administration Adverse Event Reporting System (FAERS) Database
Paul C. Guest
Current Drug Safety.2019;1134(1)1
[DOI]
17Estimating 10-year cardiovascular disease risk in Asian patients with schizophrenia
Gurpreet Rekhi,Toe Toe Khyne,Jimmy Lee
General Hospital Psychiatry.2016;43(1)46
[DOI]
18Metabolic Syndrome Screening and Assertive Community Treatment
Enrico G. Castillo,Justin Rosati,Caroline Williams,Neil Pessin,David C. Lindy
Journal of the American Psychiatric Nurses Association.2015;21(4)233
[DOI]
19An Eight-Year Clinic Experience with Clozapine Use in a Parkinson’s Disease Clinic Setting
Nawaz Hack,Sarah M. Fayad,Erin H. Monari,Umer Akbar,Angela Hardwick,Ramon L. Rodriguez,Irene A. Malaty,Janet Romrell,Aparna A. Wagle. Shukla,Nikolaus McFarland,Herbert E. Ward,Michael S. Okun,Pedro Gonzalez-Alegre
PLoS ONE.2014;9(3)e91545
[DOI]
20Can corneal confocal microscopy help in early detection of neuronal damage and cognitive dysfunction as a consequence of metabolic syndrome in schizophrenia?
Anoop Sankaranarayanan,Rayaz A. Malik
Early Intervention in Psychiatry.2017;11(3)271
[DOI]
21The Wnt Signaling Pathway Effector TCF7L2 Mediates Olanzapine-Induced Weight Gain and Insulin Resistance
Ranran Li,Jianjun Ou,Li Li,Ye Yang,Jingping Zhao,Renrong Wu
Frontiers in Pharmacology.2018;9(3)271
[DOI]
22Persistence of racial disparities in prescription of first-generation antipsychotics in the USA
Thomas B. Cook,Gloria M. Reeves,James Teufel,Teodor T. Postolache
Pharmacoepidemiology and Drug Safety.2015;24(11)1197
[DOI]
23Polygenic risk for schizophrenia, disordered eating behaviours and body mass index in adolescents
Francesca Solmi,Marina Carbo Mascarell,Stanley Zammit,James B. Kirkbride,Glyn Lewis
The British Journal of Psychiatry.2019;215(01)428
[DOI]
24Exploring shared genetic bases and causal relationships of schizophrenia and bipolar disorder with 28 cardiovascular and metabolic traits
Hon-Cheong So,Kwan-Long Chau,Fu-Kiu Ao,Cheuk-Hei Mo,Pak-Chung Sham
Psychological Medicine.2019;49(08)1286
[DOI]
25Effects of haloperidol and clozapine administration on oxidative stress in rat brain, liver and serum
Ana C. Andreazza,Vilte E. Barakauskas,Salar Fazeli,Abigail Feresten,Li Shao,Vivien Wei,Che Hsuan Wu,Alasdair M. Barr,Clare L. Beasley
Neuroscience Letters.2015;591(08)36
[DOI]
26Second-Generation Antipsychotics and Dysregulation of Glucose Metabolism: Beyond Weight Gain
Diana Grajales,Vitor Ferreira,Ángela M. Valverde
Cells.2019;8(11)1336
[DOI]
27Latent Toxoplasma gondii infection is associated with decreased serum triglyceride to high-density lipoprotein cholesterol ratio in male patients with schizophrenia
Marina Sagud,Suzana Vlatkovic,Dubravka Svob Strac,Mario Sviben,Maja Zivkovic,Maja Vilibic,Bjanka Vuksan-Cusa,Alma Mihaljevic-Peles,Nela Pivac
Comprehensive Psychiatry.2018;82(11)115
[DOI]
28Retraction: Association Between 5-HTR2C –759C/T (rs3813929) and –697G/C (rs518147) Gene Polymorphisms and Risperidone-Induced Insulin Resistance Syndrome in an Indian Population
Saibal Das,Jayanta Kumar Dey,Niranjan Prabhu,Sachin David,Aniket Kumar,Deepa Braganza,Margaret Shanthi
The Journal of Clinical Pharmacology.2018;58(3)399
[DOI]
29Weight Gain and its Correlates among Forensic Inpatients
N Zoe Hilton,Elke Ham,Carol Lang,Grant T Harris
The Canadian Journal of Psychiatry.2015;60(5)232
[DOI]
30Dysglycaemia, Inflammation and Psychosis: Findings From the UK ALSPAC Birth Cohort
Benjamin Ian Perry,Rachel Upthegrove,Andrew Thompson,Steven Marwaha,Stanley Zammit,Swaran Preet Singh,Golam Khandaker
Schizophrenia Bulletin.2019;45(2)330
[DOI]
31Prevalence of metabolic syndrome in female and male patients at risk of psychosis
Joachim Cordes,Andreas Bechdolf,Christina Engelke,Kai G. Kahl,Chakrapani Balijepalli,Christian Lösch,Joachim Klosterkötter,Michael Wagner,Wolfgang Maier,Andreas Heinz,Walter de Millas,Wolfgang Gaebel,Georg Winterer,Birgit Janssen,Christian Schmidt-Kraepelin,Frank Schneider,Martin Lambert,Georg Juckel,Thomas Wobrock,Michael Riedel,Susanne Moebus
Schizophrenia Research.2017;181(2)38
[DOI]
32Metabolic syndrome in antipsychotic naive African patients with severe mental illness in usual care
Shamima Saloojee,Jonathan K. Burns,Ayesha A. Motala
Early Intervention in Psychiatry.2018;12(6)1137
[DOI]
33Prescription preferences in antipsychotics and attitude towards the pharmaceutical industry in Belgium
Stijn Cleymans,Manuel Morrens,Chris Bervoets
Journal of Medical Ethics.2017;43(6)359
[DOI]
34QT dispersion and P wave dispersion in schizophrenia
Sema Baykara,Mücahit Yilmaz,Murat Baykara
Psychiatry and Clinical Psychopharmacology.2019;29(4)538
[DOI]
35Acute onset clozapine-induced hyperglycaemia: A case report
Pradeep Kumar,Dheerendra Kumar Mishra,Nimisha Mishra,Sunil Ahuja,Gyanendra Raghuvanshi,Vijay Niranjan
General Psychiatry.2019;32(2)e100045
[DOI]
  Feedback 
  Subscribe